Академический Документы
Профессиональный Документы
Культура Документы
CACP CHAPTER 4
PREVALENCE?
5-18% THE
OF CHILDREN
MOST COMMON PSYCHIATRIC ILLNESS IN KIDS IN ACADEMIC AND SOCIAL IMPAIRMENT PERSIST INTO ADULTHOOD
RESULT
OFTEN
Diagnostic Issues
OCD
For
adults 2.5% lifetime prevalence rate 1-2 % for children and adolescents Usually starts in early adolescence or adulthood Up to 1/3 before the onset of puberty Age pattern for males: 6-15 years old Age pattern for females: 20-29 years old With childhood onset, more common in boys than girls (3:2)
Considerations
Compulsions must be so time consuming that they take up one hour + per day, routines are intrusive, occupational or relational functioning are impaired. Obsessive thoughts are more than normal daily worry or concern Adults recognize at some time that their obsessions and compulsions are unreasonable Kids dont have that awareness.
anxiety and panic are associated features present as school failure, low self esteem, and social isolation, crying, tantrums, freezing or shrinking from social situations occur in peer settings, not just w/adults
May
Must
12%.
Initial
symptoms usually occur in childhood (especially is object, situational, animal, and blood injection types) phobia is an enduring and unreasonable fear of a specific object or situation that generally does not pose any real danger (or poses only slight danger)
Specific
MUST LOOK:
For
GAD
Lifetime prevalence 5% 50% report childhood onset Anxiety and dread are prominent and interfere w/normal functioning, including work and social relationships
Symptoms: muscle tension, headaches, nausea, sweating, increased HR, exaggerated startle response.
PTSD
Lifetime Onset
prevalence: 8%
can be any age, but usually within the first 3 months of a traumatice event when: An event involving serious harm occurred or was perceived to threaten to occur; a situation was witnessed; and the response involved fear, helplessness, and horror.
Develops
PTSD includes:
Reliving the event Persistent avoidance and limited responsivenessperson avoids situations and activities associated w/event Hyper-arousal including insomnia, irritability, concentration problems, and exaggerated startle response. Kids may have stomach problems and headaches
Prevalence is 4% in children and adolescents SX when separated from home or from an attachment figure School avoidance may develop Fear, anger, and attention seeking may also occur. SX wax and wane
Fear of unfamiliar situations Timid and shy Behavioral inhibitions Autonomic arousal (Sympathetic NS)
Neurobiology
Basal ganglia
Frontal Lobes (normally inhibits urges and the more instinctive drives and urges) Maladaptive neural pathways
predisposition (probably)
Locus Coeruleus: Increases norepinephrine release, results in physiological and behavioral arousal. Peri-aquaductal gray areas: mediates defensive behaviors, postural freezing. Parabrachial nucleus: causes increased respiration. Hypothalamic paraventricular nucleus: activates the HPA axis and release of adrenotorticoids. Hypothamamic lateral nucleus: activates the sympathetic nervous system.
2.
3. 4.
5.
promotes the passage of chloride ions into the nerve cells and makes them less excitable
GABA, cont.
The
receptor complex to which GABA binds also contains a receptor site to which BENZOS attach (BZs) theory, a person should be more or less affected by stress depending on an abundance or deficit of this chemical.
In
Pharmacology
OCD
SSRIs
Chlormipramine
(TCA) with serotonergic activity (original studies in France before meds were widely used for OCD) rate: 50-75% w/gradual symptom reduction
Response
Fig. 2-5, p. 44
Other Information:
Doses to treat OCD are generally HIGHER than doses to treat depression. See p. 59 CACP Until recently, evidence for efficacy of TX kids w/OCD was not clear but: The Pediatric OCT Treatment Study (funded by NIMH) has provided clarity. Findings suggest that TX for pediatric OCD begin with CBT alone or CBT combined with an SSRI.
Outcomes
Anxiety
Findings
strongly suggest a role for the use of fluvoxamine to treat anxiety disorders, social phobia, and childhood separation disorder (probably similar results with other SSRIs per the authors. (Preston, et al. 2006).
In spite of the lack of many evidenc based studies, clinicians often use SSRIs to treat a variety of childhood anxiety disorders and all SSRIs seem to be effective in treating panic, social phobia, and GAD. When prescribed, initial doses should be low with slow titration.
For most childhood anxiety, psychotherapy, including CBT is the treatment of choice.